Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 9:04 AM ET


Company Overview of Ophthotech Corporation

Executive Profile

David R. Guyer M.D.

Chairman and Chief Executive Officer, Ophthotech Corporation
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 14 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. David R. Guyer, M.D., Co-Founded Ophthotech Corporation and has also been its Chief Executive Officer since April 2013. Dr. Guyen serves as a Consultant on Ophthalmic Products to more than 12 different pharmaceutical companies. Dr. Guyer is a Co-Founder and Executive Chairman of Imagen Biotech, Inc. He served as Scientific Advisor of Iconic Therapeutics Inc. Dr. Guyer was a Venture Partner of SV Life Sciences Advisers LLC. Dr. Guyer joined SV Life Sciences Advisers ...

Corporate Headquarters

One Penn Plaza
New York, New York 10119

United States

Phone: 212-845-8200
Fax: --

Board Members Memberships

Executive Chairman and Co-Founder
Chairman and Chief Executive Officer
Director and Member of Nomination & Remuneration Committee
Director and Member of Nominating & Corporate Governance Committee


Yale College
Johns Hopkins University

Other Affiliations

Annual Compensation

Total Annual Compensation$545,000

Stocks Options

All Other Compensation$8,000
Exercised Options$103,730
Exercised Options Value$3,043,035
Exercisable Options$177,502
Exercisable Options Value$6,184,170
Unexercisable Options$568,726
Unexercisable Options Value$16,093,914
Total Value of Options$25,321,118
Total Number of Options$849,958

Total Compensation

Total Annual Cash Compensation$1,076,200
Total Short Term Compensation$545,000
Other Long Term Compensation$8,000
Total Calculated Compensation$5,060,110

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ophthotech Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at